These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38234844)

  • 21. The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity.
    Day JR; Münk C; Guatelli JC
    J Virol; 2004 Feb; 78(3):1069-79. PubMed ID: 14722262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
    Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
    Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
    Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
    J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annexin 2 is not required for human immunodeficiency virus type 1 particle production but plays a cell type-dependent role in regulating infectivity.
    Rai T; Mosoian A; Resh MD
    J Virol; 2010 Oct; 84(19):9783-92. PubMed ID: 20631122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphology.
    Humphrey RW; Ohagen A; Davis DA; Fukazawa T; Hayashi H; Höglund S; Mitsuya H; Yarchoan R
    Antimicrob Agents Chemother; 1997 May; 41(5):1017-23. PubMed ID: 9145862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.
    Rossio JL; Esser MT; Suryanarayana K; Schneider DK; Bess JW; Vasquez GM; Wiltrout TA; Chertova E; Grimes MK; Sattentau Q; Arthur LO; Henderson LE; Lifson JD
    J Virol; 1998 Oct; 72(10):7992-8001. PubMed ID: 9733838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression and incorporation of GagPol precursor does not impede packaging of HIV-1 tRNA(Lys3) but promotes intracellular budding of virus-like particles.
    Shehu-Xhilaga M; Lee JY; Campbell S; Marshall JA; Crowe SM; Mak J
    J Biomed Sci; 2002; 9(6 Pt 2):697-705. PubMed ID: 12432236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allosteric Regulation of HIV-1 Capsid Structure for Gag Assembly, Virion Production, and Viral Infectivity by a Disordered Interdomain Linker.
    Koma T; Kotani O; Miyakawa K; Ryo A; Yokoyama M; Doi N; Adachi A; Sato H; Nomaguchi M
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between HIV-1 genome RNA dimerization, virion maturation and infectivity.
    Ohishi M; Nakano T; Sakuragi S; Shioda T; Sano K; Sakuragi J
    Nucleic Acids Res; 2011 Apr; 39(8):3404-17. PubMed ID: 21186186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SERINC5 Can Enhance Proinflammatory Cytokine Production by Primary Human Myeloid Cells in Response to Challenge with HIV-1 Particles.
    Pierini V; Gallucci L; Stürzel CM; Kirchhoff F; Fackler OT
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33597208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity.
    Cantin R; Fortin JF; Lamontagne G; Tremblay M
    J Virol; 1997 Mar; 71(3):1922-30. PubMed ID: 9032323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.
    Shehu-Xhilaga M; Crowe SM; Mak J
    J Virol; 2001 Feb; 75(4):1834-41. PubMed ID: 11160682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulated Emission Depletion Nanoscopy Reveals Time-Course of Human Immunodeficiency Virus Proteolytic Maturation.
    Hanne J; Göttfert F; Schimer J; Anders-Össwein M; Konvalinka J; Engelhardt J; Müller B; Hell SW; Kräusslich HG
    ACS Nano; 2016 Sep; 10(9):8215-22. PubMed ID: 27517329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly (ADP-ribose) polymerase-1 regulates HIV-1 replication in human CD4+ T cells.
    Martinez ZS; Gutierrez DA; Valenzuela C; Seong CS; Llano M
    bioRxiv; 2024 Jun; ():. PubMed ID: 38915699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimized Infectivity of the Cell-Free Single-Cycle Human Immunodeficiency Viruses Type 1 (HIV-1) and Its Restriction by Host Cells.
    Kim JH; Song H; Austin JL; Cheng W
    PLoS One; 2013; 8(6):e67170. PubMed ID: 23825637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative Correlation between Infectivity and Gp120 Density on HIV-1 Virions Revealed by Optical Trapping Virometry.
    DeSantis MC; Kim JH; Song H; Klasse PJ; Cheng W
    J Biol Chem; 2016 Jun; 291(25):13088-97. PubMed ID: 27129237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity.
    Diehl WE; Guney MH; Vanzo T; Kyawe PP; White JM; Pizzato M; Luban J
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34209034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures.
    Liu H; Wu X; Newman M; Shaw GM; Hahn BH; Kappes JC
    J Virol; 1995 Dec; 69(12):7630-8. PubMed ID: 7494271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus type 1 protease inhibitors irreversibly block infectivity of purified virions from chronically infected cells.
    Lambert DM; Petteway SR; McDanal CE; Hart TK; Leary JJ; Dreyer GB; Meek TD; Bugelski PJ; Bolognesi DP; Metcalf BW
    Antimicrob Agents Chemother; 1992 May; 36(5):982-8. PubMed ID: 1510424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A C2 symmetry-based HIV protease inhibitor, A77003, irreversibly inhibits infectivity of HIV-1 in vitro.
    Kageyama S; Hoekzema DT; Murakawa Y; Kojima E; Shirasaka T; Kempf DJ; Norbeck DW; Erickson J; Mitsuya H
    AIDS Res Hum Retroviruses; 1994 Jun; 10(6):735-43. PubMed ID: 8074936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.